STOCKWATCH
·
Biotechnology: Pharmaceutical Preparations
InvestmentApr 24, 2026, 04:12 PM

Q32 Bio launches new $75M at-the-market stock offering

AI Summary

Q32 Bio Inc. announced the completion of its previous at-the-market (ATM) offering, having sold the full $14.2 million in common stock. Following this, the company initiated a new ATM offering program. This new program allows Q32 Bio to sell up to an additional $75 million in common stock through Cantor Fitzgerald & Co. to raise capital.

Key Highlights

  • Completed prior at-the-market (ATM) offering of $14.2 million.
  • Launched new ATM offering for up to $75 million in common stock.
  • Sales will be conducted through Cantor Fitzgerald & Co.
QTTB
Biotechnology: Pharmaceutical Preparations
Q32 Bio Inc.

Price Impact